ALKERMES | ALKS - 净收入

股票价格

33.31

每天变化

-0.60 -1.77%

每月一次

13.42%

每年

19.65%

Q2 预测

32.32

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 5.49B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	净收入	更改		日
AbbVie	USD 1.82B		1.63B	2025-12
Acadia Pharmaceuticals	USD 273.57M		201.79M	2025-12
ALKERMES	USD 49.34M		33.42M	2025-12
Amgen	USD 1.33B		1.88B	2025-12
Biogen	USD 466.5M		168.3M	2025-09
BioMarin Pharmaceutical	USD -46.57M		15.83M	2025-12
Bristol-Myers Squibb	USD 1.09B		1.11B	2025-12
Coherus Biosciences	USD -37.64M		2.11M	2025-12
Eli Lilly	USD 6.64B		1.05B	2025-12
Gilead Sciences	USD 2.18B		869M	2025-12
Heron Therapeutics	USD -2.95M		14.54M	2025-12
Ionis Pharmaceuticals	USD -229M		100.39M	2025-12
J&J	USD 5.24B		119M	2026-03
Malin Corporation	EUR -1.1M		2.2M	2023-12
Merck	USD 2.96B		2.82B	2025-12
Minerva Neurosciences	USD 1.44M		21.07M	2024-12
Nektar Therapeutics	USD -36.08M		978K	2025-12
Neurocrine Biosciences	USD 209.5M		102M	2025-09
Otsuka Holdings	JPY 65.49B		58.64B	2025-12
Ovoca Bio	EUR -765K		4.89M	2025-06
Pfizer	USD -1.65B		5.19B	2025-12
Regeneron Pharmaceuticals	USD 844.6M		615.4M	2025-12
Vertex Pharmaceuticals	USD 1.19B		108.2M	2025-12